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Multicompartment Polymer Vesicles with Artificial 
Organelles for Signal-Triggered Cascade Reactions 
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Organelles, i.e., internal subcompartments of cells, are fundamental to spatially 
separate cellular processes, while controlled intercompartment communication 
is essential for signal transduction. Furthermore, dynamic remodeling of the 
cytoskeleton provides the mechanical basis for cell shape transformations 
and mobility. In a quest to develop cell-like smart synthetic materials, 
exhibiting functional flexibility, a self-assembled vesicular multicompartment 
system, comprised of a polymeric membrane (giant unilamellar vesicle, 
GUV) enveloping polymeric artificial organelles (vesicles, nanoparticles), is 
herein presented. Such multicompartment assemblies respond to an external 
stimulus that is transduced through a precise sequence. Stimuli-triggered 
communication between two types of internal artificial organelles induces and 
localizes an enzymatic reaction and allows ion-channel mediated release from 
storage vacuoles. Moreover, cytoskeleton formation in the GUVs’ lumen can 
be triggered by addition of ionophores and ions. An additional level of control 
is achieved by signal-triggered ionophore translocation from organelles to the 
outer membrane, triggering cytoskeleton formation. This system is further 
used to study the diffusion of various cytoskeletal drugs across the synthetic 
outer membrane, demonstrating potential applicability, e.g., anticancer drug 
screening. Such multicompartment assemblies represent a robust system 
harboring many different functionalities and are a considerable leap in the 
application of cell logics to reactive and smart synthetic materials.
DOI: 10.1002/adfm.202002949
1. Introduction
The complex architecture of living cells, 
including simultaneous action of a myriad 
of dynamic processes, are the inspiration 
for creating sophisticated cell-like struc-
tures with the final goal of obtaining novel 
materials with cell-mimicking behaviors. 
Many aspects of living cells, including 
complex compartmentalization, energy 
transduction, signaling cascades, protein 
expression, growth and division, have 
been successfully modelled in isolation 
using artificial assemblies.[1] However, 
combining different cell functions while 
maintaining high spatiotemporal control 
remains challenging through the bottom-
up assembly of synthetic and biological 
components. Another obstacle that needs 
to be overcome in the development of cell-
mimicking materials is endowing them 
with the ability to dynamically modify their 
internal structure. In nature, cell mobility, 
shape, cell division, and intracellular 
transport rely on the dynamic assembly/
disassembly of cytoskeletal components 
(e.g., actin) in combination with the action 
of motor proteins (e.g., myosin).[2] Repro-
duction of such a complex system that maintains the mobility, 
division, and transport seen within cells, is achievable using 
manmade autonomous artificial cells, however many hurdles 
remain.[1b]
Two common membranous structures utilized for building 
cell-like entities are either lipidic or polymeric giant unila-
mellar vesicles (GUV),[1a,d] with some reports of other systems 
such as proteinosomes, coacervates, colloidosomes, polypep-
tide, or polymer capsules.[3] Lipids, as natural components of 
cell membranes, are one of the most biocompatible building 
blocks for cell-like systems. However, issues with respect to sta-
bility and tuneability of lipid-based systems explains the great 
interest in synthetic polymer-based vesicles to overcome some 
of these challenges. Since the functionality of various mem-
brane proteins can also be preserved when inserted in polymer 
membranes,[1a,4] the basis for creating complex cell-mimicking 
systems by combining synthetic and biological components is 
given. Key examples of cell mimics made from giant polymer 
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vesicles include demonstration of protein expression (actin 
monomer) via encapsulation of the whole expression machinery 
and building blocks,[5] energy production,[6] signal transduction 
via responsive subcompartments,[7] autonomous growth/bleb-
bing/division,[8] and beating.[9]
With respect to cytoskeleton components inside artificial 
assemblies, actin polymerization has been mainly studied using 
giant liposomes to observe membrane transformations that 
underlay cell motility.[1d] There are only two recent examples 
that address the complex mechanism of cytoskeleton formation 
inside artificial assemblies. In the first, microinjection of F-actin 
or polymerization during cell mimic formation using a lipid-
based GUV system produced via microfluidics and the help of 
copolymer-stabilized water-in-oil droplets, was explored.[10] In 
the second, a more complex setup was demonstrated using a 
GUV system that successfully coupled photosynthesis and actin 
polymerization.[11] This last concept was recently evaluated on 
a nanoscale tubular polymersome system.[12] However, all of 
the cell-sized systems relied on the inherently less stable lipid-
based membranes, and did not fully exploit the potentialities 
offered by a modular and stimuli-reactive system to mimic cells 
more in depth rather than focusing only on the formation of a 
cytoskeleton per se.
Subcompartmentalization of synthetic assemblies, much like 
organelles in living cells, can allow the localization of compo-
nents and their hierarchical organization in discrete, sequen-
tial steps, changing their content and their internal structure. 
We recently reported a stimuli-responsive, cell-sized, polymer-
based multicompartment system that can transduce a signal 
via triggerable subcompartments that in turn switch on an 
enzymatic reaction or deliver ion channels to the outer mem-
brane permeabilizing it towards a secondary messenger.[7] 
Our system, based on micrometer-sized polymer vesicles with 
nanosized stimuli-responsive subcompartments, serves as the 
basis for cell mimics with more complex behaviors, to obtain 
advanced materials where internal organization can be dynami-
cally changed upon a chemical stimulus. This bioinspired solu-
tion offers greater flexibility, compared to single-compartment 
systems, thanks to the intrinsic modularity of a hierarchical 
system containing different kinds of smaller, responsive sub-
compartments interacting with one another; additionally, the 
resulting compartmentalization influences positively the con-
tained reactions and processes.[1a,13]
Here, we evolved our system to create a multicompartment 
smart material that contains structurally diverse compartments, 
which can transduce an external signal between two types of 
artificial organelles. With the addition of a cytoskeleton com-
ponent (actin), such a system was able to form an internal 
cytoskeletal network (actin polymerization) via ion channel 
recruitment from the environment or even coloaded internal 
subcompartments. Using confocal microscopy, fluorescence 
correlation spectroscopy (FCS), and high-resolution fluores-
cence imaging (3D-SIM), we show that a complex signal trans-
duction via a cascade involving two different types of artificial 
organelles can be achieved. Addition of the signaling molecule 
led to a signal transduction cascade that involves selective 
activation of the first types of artificial organelles to kick start 
either enzymatic reactions or channel recruitment to the sec-
ondary artificial organelle, producing a detectable compound 
in the multicompartment’s lumen/membrane. This setup was 
used as a system for triggered actin network formation within 
polymeric GUVs, which changed their content, on demand, 
in three ways i) by selective disassembly of subcompartments 
ii) by selective ion flow and iii) by cytoskeleton formation. This 
demonstration of precise temporal control over spatially con-
fined components within a bottom-up cell mimic that performs 
complex sequential processes (a cascade, in a broad sense) 
upon applying a stimulus, opens up vast design options for 
various applications in fields such as catalysis, biosensing and 
biomedicine.
2. Results and Discussion
2.1. Coloading of Polymer Vesicles and Nanoparticles as 
Subcompartments of GUVs
Due to the high stability of polymeric membranes,[4] the 
membrane of the microscale polymer GUVs were formed 
from a mixture of poly(2-methyl-2-oxazoline)5–block–
poly(dimethylsiloxane)58–block–poly(2-methyl-2-oxazoline)5 
(PMOXA5-b-PDMS58-b-PMOXA5) and PDMS65-b-heparin 
copolymers, while loading of subcompartments was achieved 
simultaneously, using film rehydration technique in sucrose.[7] 
In the previous study we investigated the formation of one-
type multicompartments, loading nanoparticles and heparin-
nanostructures separately into GUVs (4–50 µm) which remained 
intact for at least six months.[7] To increase the complexity 
offered by such a modular system, we created two-type multi-
compartments, where two kinds of subcompartments, such as 
fluorescently labelled reduction sensitive nanoparticles (NP-
Graft) and heparin-exposing polymer vesicles or micelles were 
simultaneously used as subcompartments of GUVs, forming 
two-type multicompartments (Figure 1A–C; Table S1, Supporting 
Information). The heparin nanostructures were composed of 
polymersomes formed from a mixture of PMOXA5-b-PDMS58-
b-PMOXA5 combined with PDMS65-b-heparin, and micelles 
resulting from pure PDMS65-b-heparin, while NP-Graft was 
based on the graft copolymer (poly(2-methyl-2-oxazoline)88-
graft(SS)-poly(ε-caprolactone)238 (PMOXA88-g(SS)-PCL238), whose 
disulfide bridge disconnects in a reductive environment, 
resulting in particle disassembly and PCL aggregation and pre-
cipitation.[14] The latter is thus the responsive subcompartment; 
NP-Graft can be loaded with several hydrophobic compounds 
(Table S1, Supporting Information).
The two-type multicompartments were first characterized 
by in situ FCS assisted by fluorescence confocal laser scanning 
microscopy (CLSM) to monitor the changes in diffusion time, 
corresponding size, and number of loaded subcompartments 
over time (Figure 1; Table S2, Supporting Information).[7] Addi-
tionally, we loaded two polymersome-based subcompartments 
(Ves5), each carrying a different fluorophore (Bodipy 630/650 
and OG488), to visualize both compartments at once, with 
CLSM (Figure S1 and Table S1, Supporting Information).
The robustness of the detection system based on CLSM/
FCS enables the evaluation of the cellular signaling transduc-
tion cascade. Using this technique, we can follow the selective 
cargo release from the reduction sensitive subcompartments 
Adv. Funct. Mater. 2020, 2002949
www.afm-journal.dewww.advancedsciencenews.com
2002949 (3 of 11) © 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Figure 1. Characterization of multicompartments formed by loading GUVs with two different nanoassemblies (reduction-sensitive nanoparticles 
and nonreduction sensitive heparin nanostructures). TEM micrographs of each nanoassembly (left column), followed by a schematic illustration 
of multicompartments and their CLSM brightfield image. FCS measurement in combination with CLSM to quantify subcompartments inside giant 
vesicles (right column). FCS measurements: normalized autocorrelation curves are shown with symbols and the corresponding fits as solid lines. 
FCS measurements of the free dye (OG488 in blue, Bodipy630/650 in light blue), the nanoassemblies inside giant vesicles (OG488-loaded heparin 
nanostructures in black, Bodipy630/650-loaded NP-Graft in grey), and the free heparin nanostructures in solution (OG488 loaded heparin nanostruc-
ture in red, Bodipy630 loaded NP-Graft in light red) and Bodipy630 loaded NP-Graft in solution (light red), (right column). NP-Graft was coloaded with 
A) Ves5 (5%-Heparin vesicles), B) Ves25 (25%-Heparin vesicles), and C) M100 (100%-Heparin micelles) in giant vesicles. D) Characterization of the 
selective reduction sensitivity of two-type multicompartments (reduction-sensitive nanoparticles (NPGraft) and nonresponsive polymer vesicles (Ves)). 
Schematic illustration of multicompartment before and after addition of stimulus (DTT). The hydrodynamic diameter and number of particles (average 
in confocal volume) in the GUV show that in presence of DTT (grey) only the reduction sensitive NP-Graft disassembled, while the nonresponsive 
subcompartments (Ves) stayed intact. In absence of DTT, both subcompartments were stable (black) (N = 3 GUVs before and after DTT per channel). 
For the FCS measurements: normalized autocorrelation curves are shown with symbols, corresponding fits as solid lines, measurements of the free 
dye in blue (Bodipy630/650), particles in absence of DTT (black) and after addition of DTT (red), incubation times 24 h. The yellow star represents free 
dye. Scale bars, 200 nm for TEM and 5 µm for CLSM images.
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(NP-Graft) in the presence of the membrane-permeating dithi-
othreitol (DTT), while simultaneously ensuring that the other 
subcompartments (Ves5) remain intact (Figure 1D). In absence 
of the stimulus, both subcompartments remained intact inside 
the lumen of the GUV: N = 3.4 ± 1.9 NP-Graft and N = 0.9 ± 0.6 
Ves5 in the confocal volume. Considering the ratio between con-
focal and GUV volume, this corresponds to circa 3780 ± 740 NP-
Graft and 1000 ± 760 Ves5 vesicles in an average 1112 ± 407 µm3 
sized GUV,[7] meaning that NP-Graft occupy 0.2% of the GUV’s 
volume, and the Ves5 3.1%. After a 24 h treatment with DTT, 
the reduction sensitive NP-Graft disassembled via disulfide 
bond cleavage, as seen by the disappearance of the correlation 
curve and a drop in the number of particles in the confocal 
volume to background levels (Figure  1D). The nonresponsive 
subcompartments preserved their architecture, confirming that 
the selective disassembly of only one subcompartment was suc-
cessful. This set the basis for using this hierarchical assembly 
to create simple polymeric cell-mimicking vesicles with two 
subcompartments that act as artificial organelles performing 
cascade reactions triggered by an external signal.
2.2. Stimuli-Triggered Communication between Two Types of 
Internal Artificial Organelles
The responsive multicompartments were further upgraded 
by spatially segregating an enzyme from its substrate in two 
distinct artificial organelles. Upon arrival of a signal from the 
external medium, the enzymatic reaction should be triggered 
by recombining the substrate—released from within stim-
uli-responsive organelles—with enzymes entrapped within 
secondary organelles. The lipase substrate 1,2-Di-O-lauryl-rac-
glycero-3-(glutaric acid 6-methylresorufin ester) (DGGR) was 
incorporated in the stimuli-responsive artificial organelle (NP-
Graft) (Figure  2A; Table S1, Supporting Information). For the 
secondary artificial organelle, we entrapped the enzyme lipase 
in polymersomes (LipVes), with an adsorption efficiency of 
73% (Figures S2 and S3, Supporting Information). Both arti-
ficial organelles were coloaded into our polymer GUVs. No 
fluorescence was observed in a nonreductive environment, 
thanks to the spatial segregation of substrate and enzyme in 
the two organelles. Upon addition of the signaling molecule 
DTT to the GUVs, enzymatic substrate (DGGR) was released 
from the reduction sensitive subcompartment (NP-Graft) and 
free to interact with the enzyme in the secondary organelle 
(LipVes) forming the fluorescent product (methylresorufin) 
(Figure  2A,C; Figure S4, Supporting Information). The trig-
gered enzyme activity was achieved in 90% of GUVs where 
methylresorufin either partitioned into the hydrophobic part of 
the GUVs membrane (ring-like fluorescence), or stuck to the 
hydrophobic part of the remaining subcompartments’ mem-
brane and NP-Graft debris in the lumen of the GUV, yielding 
a uniformly dispersed fluorescence (Figure S5, Supporting 
Information). 10% of the GUVs showed no fluorescence. In 
agreement with our previous report, DTT did not noticeably 
disrupt the enzyme and the confined reaction had additional 
dependence on the diffusion of DTT across the membrane and 
its reduction of the NP-Graft.[7] All traces of nonencapsulated 
LipVes present in solution were inactivated using Orlistat, a 
lipase inhibitor. In conclusion, the lipase reaction inside the 
two-type multicompartments was successfully triggered by an 
external signal that induced a change in the internal archi-
tecture of the GUVs and released substrates reacted with the 
enzymes in the secondary organelles (LipVes). Even though 
the adsorption on vesicles did not change the overall activity 
of the enzyme, it affected the localization of the final product, 
with a significant fraction of the GUVs showing fluorescence 
in the lumen (35%, Figure S5, Supporting Information). In our 
previous study, we found more product located on the GUV’s 
membrane when lipase was encapsulated in free form.[7] It 
must be noted that the GUVs had quite a broad size distribu-
tion with sizes between 4 and 29 µm, a limitation of the film 
rehydration technique.
2.3. Reduction-Triggered Ion Release from Artificial Vacuoles
We further developed another two-type multicompartment 
system that, upon the reducing stimulus, transfers ion channels 
from one type of artificial organelles (NP-Graft) to secondary 
membranous artificial organelles acting as storage vacuoles 
(Na+Ves), hence permeabilizing them to allow the passage of 
stored monovalent cations (Figure  1C). For the on-demand 
release of sodium ions from the secondary storage organelle 
(Na+Ves), we coloaded them in GUVs together with primary 
organelles (NP-Grafts) containing peptide gramicidin A (gA), 
known to form cation-permeable channels. Following the release 
of gA from the NP-Graft, the triggered recruitment of gA to the 
Na+Ves was achieved via the externally added signaling molecule 
DTT (Figure 2B,D; Figure S6, Supporting Information). With gA 
immediately incorporated into the hydrophobic part of the mem-
brane of the Na+Ves, the sodium ions flowed from this artificial 
organelle into the GUV lumen, and there, activated the sodium 
sensitive dye Asante Natrium Green2 (ANG2). In addition, a frac-
tion of gA inserted in the GUV membrane, since it is made of 
the same polymer. The surface offered to gA by the encapsulated 
Na+Ves is roughly 125 µm2 for the sum of the encapsulated poly-
mersomes (1000 per GUV), versus 452 µm2 for the membrane of 
a GUV (volume 1112 µm3) would mean comparable recruitment 
to the artificial organelle membrane. We observed the increase in 
ANG2 fluorescence within the GUVs, which had a size distribu-
tion between 6 and 43 µm (N = 40 GUVs, Figure S7, Supporting 
Information), but could not observe any difference in kinetics 
compared to the case of insertion and ion flux across the GUV 
membrane due to gA insertion in GUVs membrane.[7] 73% of 
multicompartments were functional and induced the dye activa-
tion, via two types of artificial organelles coencapsulated within 
the GUVs. No fluorescence was detected in the remaining 27%, 
possibly due to insufficient loading of gA in NP-Graft, sodium 
ions in the Na+Ves, subcompartments into GUVs, ANG2 into the 
GUVs, or a combination thereof (Figure S7, Supporting Infor-
mation). As expected, the recruitment sequence did not occur 
in the absence of the stimuli DTT, showing no fluorescence. 
Our system was capable of triggering the recruitment of an ion 
channel from one organelle to another driving the flux of ions 
from the secondary organelle (storage vacuole), mimicking the 
flux of ions across organelles involved in several cell processes, 
such as signal transduction.[15]
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2.4. Ion-Mediated Polymerization of Actin Inside GUVs
To explore the potential of our strategy to fabricate self-
modulating multicompartment assemblies, we first investigated 
the formation of an actin cytoskeleton, thus mimicking a basic 
component of cells responsible for both, structural stability and 
dynamic shape modifications. We encapsulated purified mono-
meric actin (G-actin) into our polymer-based GUVs, again by 
film rehydration and induced a selective permeability of the 
GUVs’ membrane by entrapment of pore forming peptides 
and ion transporters, respectively (here named as ionophores). 
Upon addition of ions and their corresponding ionophores, 
such as ionomycin (IoNo) or gramicidin (gA) to the external 
medium, the GUV membrane becomes permeable to Mg2+ 
and Ca2+ (IoNo) or K+ ions (gA). The flux of ions successfully 
initiates actin polymerization inside the lumen of the multi-
compartment (Figure 3A). Ion-mediated actin filament forma-
tion is depended on the concentration and type of salts in its 
surrounding. This behavior depends on nonspecific interac-
tions of actin cation binding sites, which are known to regulate 
biological functions such as cellular motility or shape and can 
also be replicated in nonliving liposomes.[1f,12,16]
We first confirmed fluorometrically the concentration ranges 
needed for polymerization with monomeric pyrene labeled 
actin in solution, showing formation of filaments in presence of 
various salt solutions (KCl, CaCl2, and MgCl2) (Figure S8, Sup-
porting Information) at isosmotic concentrations. To enhance the 
creation of an ordered network, we mechanically stabilized our 
Figure 2. Characterization of the selective reduction sensitivity of two-type multicompartments (reduction-sensitive nanoparticles (NPGraft) and 
nonresponsive polymer vesicles (Ves)) for triggered enzyme activity and ion channel recruitment using two different internal subcompartments within 
GUVs. A) Schematic representation of enzymatic reaction using substrate (DGGR)-loaded NP-Graft and enzyme (lipase)-adsorbed polymersomes 
(LipVes), coloaded into GUVs. Substrate was released from NP-Graft in presence of DTT and transformed into the fluorescent product (methyl-
resorufin). B) Schematic representation of gA mediated release of sodium ions from subcompartments. Upon the addition of DTT, encapsulated gA 
is released from its NP-Graft and inserts into the membrane boundary of the Na+ Ves and GUV. This allows sodium ions to exit the nano-sized vesicle 
cavity and to activate the sodium sensitive dye ANG2 in lumen of the GUV. C) CLSM imaging of DGGR loaded NP-Graft and LipVes in GUVs in presence 
(top, middle) and absence (bottom) of DTT. Bright field image (left), fluorescence image (center), and histogram along diagonal of fluorescence image 
(right). Due to the hydrophobicity of methylresorufin, it either partitioned into the hydrophobic part of the GUV’s membrane or also to the remaining 
NP-Graft debris or nonresponsive LipVes membrane. D) CLSM imaging of gA loaded NP-Graft, sodium encapsulated polymersomes (Na+ Ves) and 
ANG2 co-loaded in GUVs in presence (top, middle) and absence (bottom) of DTT. Bright field image (left), fluorescence image (center) and histogram 
along diagonal of fluorescence image (right). The samples were incubated for 24 h. Scale bars, 5 µm.
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actin cytoskeleton (visualized with ATTO488-G-actin added to 
it) with the actin-binding protein filamin, which also helped the 
visualization of the filament networks,[17] which we could observe 
in ion-rich HEPES solutions (Figure S9, Supporting Informa-
tion). We then proceeded to load the proteins into the GUVs 
(actin GUVs), yielding results (Figure 3C) qualitatively consistent 
with the data published earlier in liposomes loaded with actin 
bundles.[16d,18] The hydrophobic Bodypy630/650 was used to visu-
alize the GUV membrane. For future functionalization purposes, 
we also incorporated azide-modified PMOXA-PDMS-PMOXA 
during GUV formation, to allow simple click-chemistry conju-
gation of several species, such as dibenzocyclooctine-containing 
moieties, as demonstrated with a fluorescent model compound 
conjugated after self-assembly (Figures S10 and S11, Supporting 
Figure 3. Actin filament polymerization in synthetic GUVs. Actin monomers (G-actin) and the actin crosslinker filamin was loaded into giant vesicles 
after 24 h incubation. Ionophores such as the channel gA or the organic molecule IoNo were introduced to the vesicle solution resulting in permea-
bilization of the GUV membrane towards specific ions (K+ or Ca2+ and Mg2+). A) Schematic representation of the actin polymerization in GUVs. B) In 
absence of ionophores, the monomers stayed intact and no filaments were formed since no ions could enter the GUV cavity. C) When ionophores where 
added to the surrounding solution, they reconstituted into the membrane boundary of the GUV (red). When ions enter the GUV cavity, actin starts to 
form filaments and the bundling agent filamin crosslinks the filaments into a network (green). D) Projections of actin filaments (green) polymerized in 
GUVs in presence of ionophores (gA, IoNo) and ions (K+, Ca2+, Mg2+) recorded with super-resolution 3D structured illumination microscopy (3D-SIM). 
The actin samples were incubated for 24 h. Scale bars, 5 µm.
Adv. Funct. Mater. 2020, 2002949
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Information). As shown by CLSM (Figure  3B), in absence of 
ionophores and/or salts the actin monomers remained in their 
monomeric form within the GUVs (no observed filaments). 
When ionophores and salts were added to the outside of actin 
GUVs, filaments were formed within 24 h, in 88.5% of the vesi-
cles (N = 200 GUVs) (Figure 3C; Figures S12 and S13, Supporting 
Information), thanks to the diffusion of K+ through membrane-
inserted gA, or Mg2+/Ca2+ through IoNo. The shapes of the 
formed filaments were similar, regardless of the salts. Actin fila-
ments formed either ring-like structures directly underneath the 
GUV membrane (inner leaflet), following the round membrane 
by bending the actin filaments, or formed web-like network 
structures within the GUV cavity.
To better visualize the morphology of the GUV cytoskel-
eton, we additionally used a high resolution microscopy tech-
nique, 3D structured illumination microscopy (3D-SIM), 
showing that the actin network within the GUVs is composed 
of both thin actin filaments and actin bundles with thicker 
fibers (Figure 3D). In most cases, when actin polymerized, we 
observed networks of actin within the GUVs and ring-like for-
mations underneath the membrane. This is due to the vesicular 
morphology of our multicompartments that usually forces the 
polymerized actin to organize into cortical rings or web-like 
construct, minimizing the energy cost associated with bending 
of filaments, as demonstrated in lipid-based systems.[16d] As 
we did not observe any filaments formed by nonencapsulated 
actin, when tested with the same salts and actin concentra-
tions present in the surrounding of GUVs, we conclude that 
any actin not encapsulated during the GUV formation process 
would be below the critical concentration of actin needed for 
polymerization to occur (Figure S14, Supporting Information). 
Therefore, no further removal of unencapsulated actin was nec-
essary prior to imaging. Our observations confirmed that we 
could successfully trigger salt-induced actin polymerization in 
polymeric GUVs via addition of ionophores.
2.5. Triggered Actin Polymerization in GUVs through a Signaling 
Cascade
Aiming at increasing the complexity of our polymer-based cell 
mimics, we combined triggerable artificial organelles with 
cytoskeleton components to achieve signal-induced cytoskel-
eton formation inside the vesicle with the first signal being 
transduced via responsive subcompartments (“actin MCs”). The 
actin filaments should only form in the presence of an exter-
nally added signal that acts on the stimuli-responsive artificial 
organelle. Upon release of ion channels from these artificial 
organelles and inside-out insertion into the GUV membrane, 
ion influx from the environment should trigger actin 
polymerization (Figure  4A). Reduction sensitive subcompart-
ments (NP-Graft), loaded with either gA or IoNo, were encapsu-
lated in GUVs together with actin monomers and filamin. Actin 
stayed monomeric within the GUV in the absence of the signal 
(DTT), ions, or both signal and ions (Figure  4B; Figure S15, 
Supporting Information). In presence of DTT, the ionophore-
loaded NP-Graft disassembled and released their cargo. As 
already observed with the addition from the outside, gA or 
IoNo incorporated into the GUV membrane allowing the 
passage of K+, Mg2+ or Ca2+ through the membrane from the 
exterior solution, leading to the polymerization of actin in the 
GUV (Figure 4C–E; Figures S16 and S17, Supporting Informa-
tion). Observations of mostly cortical rings in the case of trig-
gered actin polymerization via responsive artificial organelles 
(Figure 3) could be due to a lower amount of gA or IoNo incor-
porated into the membrane compared to addition from the out-
side, as it depends on the loading and subsequent release from 
subcompartments (Graft-NPs). Limited amount of ion influx 
could lead to a more localized actin polymerization directly 
below the membrane where the local concentration of ions will 
be highest upon channel insertion. This explanation is also 
suggested by the fact that addition of ionophores from the out-
side (Figure 3) allows fast and plentiful influx of ions that leads 
to a higher probability of creating extended networks within the 
lumen, whereas the actin rings below the membrane are also 
present in the cases of increased ion influx (Figure 3D). Such 
mechanistic considerations will need to be further investigated 
in the future.
In absence of actin, the GUVs were spherical (Figure S18, 
Supporting Information) and impermeable, likewise when 
loaded with monomeric actin (1% nonspherical shape, N  = 
200  GUVs) (Figures  3B and  4B). The actin filaments spanned 
several µm vertically, showing a cytoskeleton developing in 
various shapes within the GUV (Figure S19, Supporting Infor-
mation). Permeabilization mainly conserved the spherical 
shape, but we also observed membrane deformations, due to 
the bundled up confined filaments (28.5%, N = 200 GUVs) (Fig-
ures S20 and S21, Supporting Information).
Previous studies have revealed such changes in morphology 
with actin filaments in lipid structures, including protruded 
shapes, where the driving force for membrane deformations 
(elongation, contractions and protrusion) is generated in crowded 
condition in the compartment, as in living cells.[16d,19] Lipid 
membranes are known to be fluid-like and easily deformable 
compared to polymeric membranes that are less fluid/deform-
able when the membrane is thicker than the lipidic one.[20] 
The mechanical stress of actin filaments make giant liposomes 
more deformable and less stable;[19] our synthetic actin-GUVs 
were stable for at least 48 h, thanks to the higher stability of the 
polymer membrane. Stiffer actin bundles, formed due to higher 
filamin concentration, remain straight resulting in elongation 
of the vesicular structures or even puncturing the membrane 
due to inability to bend the actin bundles.[16d] Also in nature, 
the membrane tension of cells acts as a regulator of cytoskel-
eton architecture.[21] This behavior was more evident when gA or 
IoNo were added from the outside, i.e., without the DTT-induced 
release from subcompartments, probably due to partial reduction 
and denaturation of filamin by DTT, thus decreasing the bundle 
thickness.[22] On occasion, the stiff filaments pierced through the 
polymeric membrane and connected polymer compartments 
(Figure S21, Supporting Information), sometimes even con-
necting actin protrusions along the inner leaflet between GUVs 
(Figures S22 and S23, Supporting Information).
The cytoskeleton, as a molecular crowding agent, increases 
the internal viscosity of cells;[23] thus, we employed in situ FCS 
measurements to study the viscosity changes inside our actin 
MCs due to triggered actin polymerization. We used GUVs 
filled with responsive ionophores loaded artificial organelles 
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(IoNo-loaded NP-Graft) and nonresponsive fluorescent sub-
compartments (SRBVes), plus actin and filamin. We meas-
ured the diffusivity of the labelled nonresponsive subcom-
partments (SRBVes) before and after selective disassembly 
of NP-Graft by adding DTT and subsequent formation of 
filaments after ion influx. Based on the change in SRBVes dif-
fusion times from 4555 to 70 277 µs of otherwise unchanged 
vesicles, we could calculate a change of internal dynamic 
viscosity from 1.3 × 10−3 Pa s (viscosity of 300 × 10−3 m sucrose) 
to 1.4 × 10−2 Pa s after polymerization, yielding a relative viscosity 
Figure 4. Stimuli-triggered actin polymerization in synthetic multicompartments (“actin MCs”). A) Schematic representation of ion import inducing 
selective membrane permeabilization that results in the formation of actin filaments. Upon DTT addition, the encapsulated ionophores are released 
from its NP-Graft and inserts into the GUV membrane boundary. Ions enter from the surrounding solution into the cavity of the GUV, where the actin 
monomers start to polymerize into filamentous structures. B) CLSM imaging of actin monomer (G-actin, green) and crosslinker filamin coloaded GUVs 
(red) remaining in its monomeric form in absence of salts and ionophores. C) One slice of Figure 3D. Actin filaments (green) and GUV membrane 
(red), where actin polymerization is induced in presence of DTT. D) Projections of actin filaments (green) in GUVs (red) via stimuli responsiveness 
via internal subcompartments, were imaged with CLSM. The actin samples were incubated for 24 h. Each single slice is shown in Figure S17 in the 
Supporting Information. Scale bars, 5 µm. E) CLSM micrographs of actin filaments (green) in the lumen and inner leaflet of the GUV membrane (red), 
where actin polymerization is induced in presence of DTT. F) FCS autocorrelation curve of SRBVes of two-type multicompartments before and after 
triggered actin filament polymerization. Change in diffusion time can be indicated as viscosity change. (N = 3 GUVs before and after addition of DTT).
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ηr = 10.51. The actin filaments within the GUV made the lumen 
more crowded, replicating the molecular crowding of cells 
(Figure 4F). We successfully demonstrated that polymeric mem-
branes and the actin biopolymers regulate each other’s confor-
mation in a force balance, where the membrane acts as barrier 
for selective diffusion of molecules, and frames actin bun-
dles, which in turn influence the membrane shape. The actin 
component in our multicompartment system, combined with 
functional artificial organelles, provides a complex and highly 
controlled active material, a step forwards bringing us closer to 
mimicking the complex mechanisms involved in cellular move-
ment, shape, cell division, and intracellular transport.
We then performed a complete morphology analysis. 
Regarding the shape of the cytoskeleton, we could remark that 
web-like structures were the main type for actin GUVs (between 
71% and 92%). In contrast, formation of cortical actin rings was 
predominantly observed for actin MCs (between 75% and 80%, 
N = 100 GUVs) (Figure 5A,B). The shape of nonspherical actin 
MCs was also analyzed: the biggest population was represented 
by elongated vesicles (38%), then vesicles connected through 
tubular protrusions of their nonruptured membranes (“beads 
on a string”) and finally round vesicles showing long protru-
sions (N = 60 GUVs) (Figure 5C). All these shapes were formed 
by underlying cortical actin rings. Various parameters such as 
concentrations of actin, filamin, ions, ionophores, stiffness of 
the membrane and of the filaments and more, influence the 
overall shape of the GUVs, which will have to be studied in 
more detail to depict the mechanism by which these structures 
are formed and how they dynamically change over time.
2.6. The Influence of the Membrane on the Diffusion of 
Polymerization Inhibitors
Actin polymerization is the main target of several natural 
compounds, which exert their toxic activity by inhibiting the 
polymerization of actin, which leads to aberrations in cell trans-
port, motility and division.[24] Such natural toxins are candidate 
cytoskeletal drugs, as their interaction with actin can be a way 
to inhibit cell proliferation, making them anticancer agents, or 
Figure 5. Analysis of actin filament shapes, GUV shapes and the effect of actin polymerization inhibitors on Actin MCs. A) An actin GUV with a cortical 
ring cytoskeleton. B) Bar graph showing filament shape frequency for actin GUVs (solid color) and actin MCs (striped color), in presence of different 
salts. Green: cortical rings, blue: web-like networks. The population of cortical rings increases noticeably in actin MCs (N = 100). C) Shape distribution 
of nonspherical Actin MCs, showing a prevalence of elongated vesicles with cortical rings, closely followed by bead-like structures and then vesicles 
with protrusions (N = 60). D) Relative F-ratio of untreated Actin MCs (set as 100%) and MCs treated with different toxins. The F-ratio determines how 
much a molecule can hinder the polymerization of actin. Error bars given as Mean ± SD (binomial distribution), n between 15 (ChaetA) to 55 (CytD). 
Values compared through one-way ANOVA, with Tukey’s post hoc test. *** p < 0.001; n.s. not significant. Scalebar, 5 µm.
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biopesticides.[25] These toxins have different potency, meaning 
that the concentrations needed to achieve an effect can vary due 
to various uptake mechanisms and interactions with other cel-
lular targets.[25b] An important factor to consider, when studying 
cytoskeletal drugs, is whether they rely on passive diffusion or 
transporters;[26] additionally, secondary targets for the toxins in 
cells must be accounted for when characterizing their interac-
tion with actin, as the observed cytotoxicity might derive also 
from other interactions.[25a]
Our system can be used as a cytoskeletal drug screening 
platform to study the inhibitory action of small molecule actin-
polymerization inhibitors. This system developed by narrowing 
down “cells” into two components: a cell-mimicking mem-
brane, through which molecules can only passively diffuse, 
and a cytosol-mimicking lumen containing actin, will allow us 
to study the direct effect of the drugs on mechanical properties 
of cell-like systems.[27] To test such an application, we induced 
actin polymerization through DTT-triggered release of iono-
mycin from NP-Graft and flow of Mg2+ in presence and absence 
of externally added actin polymerization inhibitors. As a proof 
of concept, we tested four different toxins, all membrane-perme-
able: latrunculin A (LatA), chaetoglobosin A (ChaetA), cytocha-
lasin B (CytB), and cytochalasin D (CytD). The simultaneous 
addition of one of four toxins meant that the DTT-triggered actin 
polymerization had to compete with the compounds, which had 
in turn to diffuse across the polymer membrane. All screened 
compounds were added at the same concentration, above their 
reported EC50,[28] so that the only discriminants would be their 
ability to cross the membrane, and their intrinsic activity. All 
toxins showed significant ability of reducing what we called rela-
tive F-ratio, the ratio between GUVs presenting at least one fila-
ment and the total population, compared to the untreated MCs. 
We observed the highest effect with LatA, known to be one of 
the most potent polymerization inhibitors.[29] We found no sig-
nificant differences between Chaet A, CytB, and CytD. These 
results suggest that the differences in potency between the 
compounds could partially be explained by their ability to dif-
fuse through membranes, in addition to their intrinsic activity 
(Figure 5D). ChaetA was a remarkable case, as its addition led 
to the disassembly of a great number of vesicles (Figure S24, 
Supporting Information), hinting that it interacts with both the 
membrane and actin, which could be a future research direc-
tion to elucidate its toxic action in biological settings. We envi-
sion that finding polymerization inhibition in our system is an 
indicator of potential toxicity of the compound, since the com-
pound could act on many different cells in the body through 
passive diffusion across the membrane. Interesting drug can-
didates would be inhibitors of actin polymerization in solution, 
but present no activity in our system. Such compounds could 
potentially be delivered to cancer cells specifically using targeted 
nanocarriers. Our findings present a possible application of our 
system, to screen for specific parameters affecting the action of 
compounds of pharmacological interest.
3. Conclusions
In conclusion, we demonstrated that our hybrid protein–
polymer cell-like system is a responsive multicompartment 
platform able to modify, selectively and following a chemical 
stimulus, its internal structure and content, mimicking aspects 
of cell behavior. These changes included triggered enzymatic 
activity, controlled membrane permeability, and cytoskel-
eton formation, achieving a self-contained and self-regulating 
responsive material, which can change its internal architec-
ture and content with a complex tunable series of sequential 
steps. This complex and bio-inspired construct is a promising 
platform for the development of smart materials, sensing 
external factors and responding accordingly, with potential 
applications in biosensing and theranostics. As a first proof of 
concept, we showed how we could differentiate the influence 
of cross-membrane diffusion of different actin polymeriza-
tion inhibitors. Future research will aim at using less potent 
reducing agents (e.g., GSH), which will require insertion of 
additional membrane proteins to permeabilize the polymeric 
membrane for such molecules.[30] The lack of control over the 
size distribution of multicompartments will be improved with 
the adoption of a microfluidic-based assembly approach.[31] We 
envision that the reported strategy has the potential to include 
even more complex functionalities by exchanging the trigger 
(signaling molecules), subcompartments (artificial organelles), 
and surface components to progress towards creation of an 
artificial cell.
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